Related content

An Open-label Study of Tiagabine as Augmentation Therapy for Anxiety

By Schwartz Thomas   Azhar Nouman   Husain Juhi   Nihalani Nikhil   Simionescu Mihai   Coovert Douglas   Jindal Shefali   Tirmazi Syed  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 17, Iss. 3, 2005-07 ,pp. : 167-172

Informa Healthcare

Access to resources Recommend Favorite

The KEEPER&unknown; trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study

By Morrell M.J.   Leppik I.   French J.   Ferrendelli J.   Han J.   Magnus L.  

Epilepsy Research, Vol. 54, Iss. 2, 2003-05 ,pp. : 153-161

Elsevier

Access to resources Recommend Favorite

Corrigendum to ''The KEEPER(TM) trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study'' [Epilepsy Res. 54 (2003) 153-162]

By Morrell M.J.   Leppik I.   French J.   Ferrendelli J.   Han J.   Magnus L.  

Epilepsy Research, Vol. 56, Iss. 2, 2003-10 ,pp. : 209-210

Elsevier

Access to resources Recommend Favorite

Efficacy and tolerability of quetiapine in cluster B personality disorder: an open-label study

By Bloc'h Yves Le   Baumann Pierre   Stigler Michael   Eap Chin B.   Zullino Daniele F.  

International Journal of Psychiatry in Clinical Practice, Vol. 11, Iss. 2, 2007-01 ,pp. : 123-128

Ashgate Publishing Ltd

Access to resources Recommend Favorite

A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

By Kalviainen R.   Brodie M.J.   Duncan J.   Chadwick D.   Edwards D.   Lyby K.   for the Northern European Tiagabine Study Group  

Epilepsy Research, Vol. 30, Iss. 1, 1998-03 ,pp. : 31-40

Elsevier

Access to resources Recommend Favorite